Canadian Healthcare Professionals’ Views and Attitudes toward Risk-Stratified Breast Cancer Screening

Author:

Lapointe Julie1,Côté Jean-Martin1,Mbuya-Bienge Cynthia12,Dorval Michel134ORCID,Pashayan Nora5ORCID,Chiquette Jocelyne16,Eloy Laurence7,Turgeon Annie1,Lambert-Côté Laurence1ORCID,Brooks Jennifer D.8ORCID,Walker Meghan J.89,Blackmore Kristina Maria9,Joly Yann1011,Knoppers Bartha Maria10ORCID,Chiarelli Anna Maria89,Simard Jacques112ORCID,Nabi Hermann12ORCID

Affiliation:

1. Oncology Division, CHU de Québec-Université Laval Research Center, 1050, Chemin Sainte-Foy, Québec City, QC G1S 4L8, Canada

2. Department of Social and Preventive Medicine, Faculty of Medicine, Université Laval, 1050, Av de la Médecine, Québec City, QC G1V 0A6, Canada

3. Faculty of Pharmacy, Université Laval, 1050, Av de la Médecine, Québec City, QC G1V 0A6, Canada

4. CISSS de Chaudière-Appalaches Research Center, 143 Rue Wolfe, Lévis, QC G6V 3Z1, Canada

5. Department of Applied Health Research, Institute of Epidemiology and Healthcare, University College London, Gower Street, London WC1E 6BT, UK

6. CHU de Québec—Université Laval, 1050, Chemin Sainte-Foy, Québec City, QC G1S 4L8, Canada

7. Programme Québécois de Cancérologie, Ministère de la Santé et des Services Sociaux, 1075, Chemin Sainte-Foy, Québec City, QC G1S 2M1, Canada

8. Dalla Lana School of Public Health, University of Toronto, 155, College Street, Toronto, ON M5T 3M7, Canada

9. Cancer Care Ontario, Ontario Health, 525, University Avenue, Toronto, ON M5G 2L3, Canada

10. Centre of Genomics and Policy, McGill University, 740, Ave Penfield, Montreal, QC H3A 0G1, Canada

11. Human Genetics Department and Bioethics Unit, Faculty of Medicine, McGill University, 3647, Peel Street, Montreal, QC G1V 0A6, Canada

12. Department of Molecular Medicine, Faculty of Medicine, Université Laval, 1050, Avenue de la Médecine, Québec City, QC G1V 0A6, Canada

Abstract

Given the controversy over the effectiveness of age-based breast cancer (BC) screening, offering risk-stratified screening to women may be a way to improve patient outcomes with detection of earlier-stage disease. While this approach seems promising, its integration requires the buy-in of many stakeholders. In this cross-sectional study, we surveyed Canadian healthcare professionals about their views and attitudes toward a risk-stratified BC screening approach. An anonymous online questionnaire was disseminated through Canadian healthcare professional associations between November 2020 and May 2021. Information collected included attitudes toward BC screening recommendations based on individual risk, comfort and perceived readiness related to the possible implementation of this approach. Close to 90% of the 593 respondents agreed with increased frequency and earlier initiation of BC screening for women at high risk. However, only 9% agreed with the idea of not offering BC screening to women at very low risk. Respondents indicated that primary care physicians and nurse practitioners should play a leading role in the risk-stratified BC screening approach. This survey identifies health services and policy enhancements that would be needed to support future implementation of a risk-stratified BC screening approach in healthcare systems in Canada and other countries.

Funder

Government of Canada through Genome Canada

Canadian Institutes of Health Research

Ministère de l’Économie et de l’Innovation du Québec through Genome Québec, the Quebec Breast Cancer Foundation, Canada

CHU de Québec Foundation

Ontario Research Fund

Quebec Research Fund—Health

anada Research Chair in Law and Medicine

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Reference53 articles.

1. International Agency for Cancer Research of the World Health Organization (2023, March 30). Current and Future Burden of Breast Cancer: Global Statistics for 2020 and 2040. Available online: https://www.iarc.who.int/news-events/current-and-future-burden-of-breast-cancer-global-statistics-for-2020-and-2040/.

2. (2023, April 11). Public Health Agency of Canada Breast Cancer. Available online: https://www.canada.ca/en/public-health/services/chronic-diseases/cancer/breast-cancer.html.

3. (2023, April 11). Canadian Task Force on Preventive Health Care Breast Cancer Update. Available online: https://canadiantaskforce.ca/guidelines/published-guidelines/breast-cancer-update/.

4. The benefits and harms of breast cancer screening: An independent review;Marmot;Br. J. Cancer,2013

5. Brooks, J.D., Nabi, H.H., Andrulis, I.L., Antoniou, A.C., Chiquette, J., Després, P., Devilee, P., Dorval, M., Droit, A., and Easton, D.F. (2021). Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I). J. Pers. Med., 11.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Familial Cancers;International Encyclopedia of Public Health;2025

2. Healthcare professionals' knowledge and attitudes towards polygenic risk testing for glaucoma;Clinical & Experimental Ophthalmology;2024-09-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3